We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECTE
2576
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$141K ﹤0.01%
+56,607
New +$297K
SPRO
2577
DELISTED
SMARTPROS LTD COM STK
SPRO
$141K ﹤0.01%
+80,700
New +$130K
VISN
2578
DELISTED
VisionChina Media, Inc.
VISN
$141K ﹤0.01%
+70,355
New +$183K
AIFC
2579
AI Financial Corp
AIFC
$55.6M
$140K ﹤0.01%
+10,860
New +$101K
BSF
2580
DELISTED
Bear State Financial, Inc.
BSF
$140K ﹤0.01%
+19,676
New +$168K
KID
2581
DELISTED
KID BRANDS,INC COMMON STOCK
KID
$140K ﹤0.01%
+91,200
New +$131K
EDN
2582
Edenor
EDN
$1.14B
$139K ﹤0.01%
+68,300
New +$149K
FUSB icon
2583
First US Bancshares
FUSB
$93.1M
$139K ﹤0.01%
+14,100
New +$122K
ULBI icon
2584
Ultralife
ULBI
$90.1M
$137K ﹤0.01%
+38,500
New +$150K
TCCO
2585
DELISTED
Technical Communications Corporation
TCCO
$137K ﹤0.01%
+18,000
New +$124K
DOM
2586
DELISTED
DOMINION RES BLACK WARRIOR TR
DOM
$137K ﹤0.01%
+32,681
New +$166K
PRXI
2587
DELISTED
PREMIER EXHIBITIONS INC COM STK NEW (FL)
PRXI
$137K ﹤0.01%
+7,860
New +$179K
QBAK
2588
DELISTED
Qualstar Corp
QBAK
$136K ﹤0.01%
+16,200
New +$162K
ABR icon
2589
Arbor Realty Trust
ABR
$977M
$133K ﹤0.01%
+21,200
New +$152K
SGMO
2590
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$133K ﹤0.01%
+17,000
New +$148K
TECUB
2591
DELISTED
TECUMSEH PRODUCTS CO CL-B
TECUB
$132K ﹤0.01%
+11,900
New +$132K
AEHL icon
2592
Antelope Enterprise Holdings
AEHL
$11.8M
$130K ﹤0.01%
+1
New +$125K
BSPM
2593
DELISTED
Biostar Pharmaceuticals, Inc.
BSPM
$130K ﹤0.01%
+26,953
New +$150K
FAC
2594
DELISTED
First Acceptance Corp.
FAC
$130K ﹤0.01%
+79,400
New +$107K
LTRX icon
2595
Lantronix
LTRX
$244M
$126K ﹤0.01%
+79,666
New +$146K
SORL
2596
DELISTED
SORL Auto Parts, Inc.
SORL
$125K ﹤0.01%
+47,600
New +$133K
CTLP
2597
DELISTED
Cantaloupe
CTLP
$122K ﹤0.01%
+69,915
New +$141K
IFO
2598
DELISTED
INFOSONICS CORPORATION
IFO
$120K ﹤0.01%
+266,614
New +$120K
ENG
2599
DELISTED
ENGlobal Corp
ENG
$118K ﹤0.01%
+15,500
New +$73.5K
STLY
2600
DELISTED
Stanley Furniture Co Inc
STLY
$118K ﹤0.01%
+29,512
New +$120K

Similar funds

Renaissance Technologies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.